Skip to main content
Erschienen in: Diabetologia 4/2010

01.04.2010 | For Debate

The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation

verfasst von: R. K. Simmons, K. G. M. M. Alberti, E. A. M. Gale, S. Colagiuri, J. Tuomilehto, Q. Qiao, A. Ramachandran, N. Tajima, I. Brajkovich Mirchov, A. Ben-Nakhi, G. Reaven, B. Hama Sambo, S. Mendis, G. Roglic

Erschienen in: Diabetologia | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

This article presents the conclusions of a WHO Expert Consultation that evaluated the utility of the ‘metabolic syndrome’ concept in relation to four key areas: pathophysiology, epidemiology, clinical work and public health. The metabolic syndrome is a concept that focuses attention on complex multifactorial health problems. While it may be considered useful as an educational concept, it has limited practical utility as a diagnostic or management tool. Further efforts to redefine it are inappropriate in the light of current knowledge and understanding, and there is limited utility in epidemiological studies in which different definitions of the metabolic syndrome are compared. Metabolic syndrome is a pre-morbid condition rather than a clinical diagnosis, and should thus exclude individuals with established diabetes or known cardiovascular disease (CVD). Future research should focus on: (1) further elucidation of common metabolic pathways underlying the development of diabetes and CVD, including those clustering within the metabolic syndrome; (2) early-life determinants of metabolic risk; (3) developing and evaluating context-specific strategies for identifying and reducing CVD and diabetes risk, based on available resources; and (4) developing and evaluating population-based prevention strategies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat World Health Organization (2008) 2008–2013 Action plan for the global strategy for the prevention and control of noncommunicable diseases. WHO, Geneva World Health Organization (2008) 2008–2013 Action plan for the global strategy for the prevention and control of noncommunicable diseases. WHO, Geneva
2.
Zurück zum Zitat United Nations (2008) The Millennium Development Goals report 2008. United Nations, New York United Nations (2008) The Millennium Development Goals report 2008. United Nations, New York
3.
Zurück zum Zitat Reaven GM (1988) Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607CrossRefPubMed Reaven GM (1988) Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607CrossRefPubMed
4.
Zurück zum Zitat World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. WHO, Geneva World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. WHO, Geneva
5.
Zurück zum Zitat Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433–438CrossRefPubMed Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433–438CrossRefPubMed
6.
Zurück zum Zitat Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16:442–443CrossRefPubMed Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16:442–443CrossRefPubMed
7.
Zurück zum Zitat Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome—a new worldwide definition. Lancet 366:1059–1062CrossRefPubMed Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome—a new worldwide definition. Lancet 366:1059–1062CrossRefPubMed
8.
Zurück zum Zitat Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645CrossRefPubMed Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645CrossRefPubMed
9.
Zurück zum Zitat Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 48:1684–1699CrossRefPubMed Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 48:1684–1699CrossRefPubMed
10.
11.
Zurück zum Zitat Carr DB, Utzschneider KM, Hull RL et al (2004) Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53:2087–2094CrossRefPubMed Carr DB, Utzschneider KM, Hull RL et al (2004) Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53:2087–2094CrossRefPubMed
12.
Zurück zum Zitat Ford ES (2005) Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28:1769–1778CrossRefPubMed Ford ES (2005) Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28:1769–1778CrossRefPubMed
13.
Zurück zum Zitat Fernandez-Twinn DS, Ozanne SE (2006) Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome. Physiol Behav 88:234–243CrossRefPubMed Fernandez-Twinn DS, Ozanne SE (2006) Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome. Physiol Behav 88:234–243CrossRefPubMed
14.
Zurück zum Zitat Sjogren M, Lyssenko V, Jonsson A et al (2008) The search for putative unifying genetic factors for components of the metabolic syndrome. Diabetologia 51:2242–2251CrossRefPubMed Sjogren M, Lyssenko V, Jonsson A et al (2008) The search for putative unifying genetic factors for components of the metabolic syndrome. Diabetologia 51:2242–2251CrossRefPubMed
15.
Zurück zum Zitat Kotronen A, Yki-Jarvinen H (2008) Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 28:27–38CrossRefPubMed Kotronen A, Yki-Jarvinen H (2008) Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 28:27–38CrossRefPubMed
16.
Zurück zum Zitat Vgontzas AN, Bixler EO, Chrousos GP (2005) Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9:211–224CrossRefPubMed Vgontzas AN, Bixler EO, Chrousos GP (2005) Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9:211–224CrossRefPubMed
17.
Zurück zum Zitat Russo A, Autelitano M, Bisanti L (2008) Metabolic syndrome and cancer risk. Eur J Cancer 44:293–297CrossRefPubMed Russo A, Autelitano M, Bisanti L (2008) Metabolic syndrome and cancer risk. Eur J Cancer 44:293–297CrossRefPubMed
18.
Zurück zum Zitat Wild SH, Byrne CD (2005) The global burden of the metabolic syndrome and its consequences for diabetes and cardiovascular disease. In: Wild SH, Byrne CD (eds) The metabolic syndrome. Wiley, Chichester, pp 1–43 Wild SH, Byrne CD (2005) The global burden of the metabolic syndrome and its consequences for diabetes and cardiovascular disease. In: Wild SH, Byrne CD (eds) The metabolic syndrome. Wiley, Chichester, pp 1–43
19.
Zurück zum Zitat Weiss R, Dziura J, Burgert TS et al (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362–2374CrossRefPubMed Weiss R, Dziura J, Burgert TS et al (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362–2374CrossRefPubMed
20.
Zurück zum Zitat Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A, Azizi F (2006) High prevalence of the metabolic syndrome in Iranian adolescents. Obesity 14:377–382CrossRefPubMed Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A, Azizi F (2006) High prevalence of the metabolic syndrome in Iranian adolescents. Obesity 14:377–382CrossRefPubMed
21.
Zurück zum Zitat Reaven GM (2006) The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 83:1237–1247PubMed Reaven GM (2006) The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 83:1237–1247PubMed
22.
Zurück zum Zitat Eddy DM, Schlessinger L, Heikes K (2008) The metabolic syndrome and cardiovascular risk: implications for clinical practice. Int J Obes 32(Suppl 2):S5–10CrossRef Eddy DM, Schlessinger L, Heikes K (2008) The metabolic syndrome and cardiovascular risk: implications for clinical practice. Int J Obes 32(Suppl 2):S5–10CrossRef
23.
Zurück zum Zitat Lee CM, Huxley RR, Woodward M et al (2008) The metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region. Diabetes Res Clin Pract 8:377–380CrossRef Lee CM, Huxley RR, Woodward M et al (2008) The metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region. Diabetes Res Clin Pract 8:377–380CrossRef
24.
Zurück zum Zitat Sattar N, McConnachie A, Shaper AG et al (2008) Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 371:1927–1935CrossRefPubMed Sattar N, McConnachie A, Shaper AG et al (2008) Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 371:1927–1935CrossRefPubMed
25.
Zurück zum Zitat Kohli P, Greenland P (2006) Role of the metabolic syndrome in risk assessment for coronary heart disease. JAMA 295:819–821CrossRefPubMed Kohli P, Greenland P (2006) Role of the metabolic syndrome in risk assessment for coronary heart disease. JAMA 295:819–821CrossRefPubMed
26.
Zurück zum Zitat Cameron AJ, Magliano DJ, Zimmet PZ et al (2008) The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med 264:177–186CrossRefPubMed Cameron AJ, Magliano DJ, Zimmet PZ et al (2008) The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med 264:177–186CrossRefPubMed
27.
Zurück zum Zitat Mancia G, Bombelli M, Corrao G et al (2007) Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 49:40–47CrossRefPubMed Mancia G, Bombelli M, Corrao G et al (2007) Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 49:40–47CrossRefPubMed
28.
Zurück zum Zitat Stevens J, McClain JE, Truesdale KP (2008) Selection of measures in epidemiologic studies of the consequences of obesity. Int J Obes 32(Suppl 3):S60–S66CrossRef Stevens J, McClain JE, Truesdale KP (2008) Selection of measures in epidemiologic studies of the consequences of obesity. Int J Obes 32(Suppl 3):S60–S66CrossRef
29.
Zurück zum Zitat Canoy D (2008) Distribution of body fat and risk of coronary heart disease in men and women. Curr Opin Cardiol 23:591–598CrossRefPubMed Canoy D (2008) Distribution of body fat and risk of coronary heart disease in men and women. Curr Opin Cardiol 23:591–598CrossRefPubMed
30.
Zurück zum Zitat Mendis S, Lindholm LH, Mancia G et al (2007) World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens 25:1578–1582CrossRefPubMed Mendis S, Lindholm LH, Mancia G et al (2007) World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens 25:1578–1582CrossRefPubMed
31.
Zurück zum Zitat Kohro T, Furui Y, Mitsutake N et al (2008) The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome. Int Heart J 49:193–203CrossRefPubMed Kohro T, Furui Y, Mitsutake N et al (2008) The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome. Int Heart J 49:193–203CrossRefPubMed
32.
Zurück zum Zitat Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49:289–297CrossRefPubMed Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49:289–297CrossRefPubMed
33.
Zurück zum Zitat Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350CrossRefPubMed Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350CrossRefPubMed
34.
Zurück zum Zitat Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403CrossRefPubMed Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403CrossRefPubMed
35.
Zurück zum Zitat Eyre H, Kahn R, Robertson RM et al (2004) Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation 109:3244–3255CrossRefPubMed Eyre H, Kahn R, Robertson RM et al (2004) Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation 109:3244–3255CrossRefPubMed
Metadaten
Titel
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation
verfasst von
R. K. Simmons
K. G. M. M. Alberti
E. A. M. Gale
S. Colagiuri
J. Tuomilehto
Q. Qiao
A. Ramachandran
N. Tajima
I. Brajkovich Mirchov
A. Ben-Nakhi
G. Reaven
B. Hama Sambo
S. Mendis
G. Roglic
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 4/2010
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1620-4

Weitere Artikel der Ausgabe 4/2010

Diabetologia 4/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.